Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Belite, Celltrion, Chiesi, GSK, Lundbeck, Minovia, Sichuan Kelun-Biotech, Teva.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Agios, Artiva, Atai, Beckley, Celltrion, Chiesi, Disc, Insmed, Kiniksa, Novartis, Protalix, Regeneron, Revolution, Roche, Sanofi, Sichuan Kelun.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Enterome, Pharmther.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aptar, Scanogen.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Belite, Chiesi, Minovia, Transpire.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Micro Interventional Devices, Ocusciences, Owlet, Vara.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Abbvie, Akamis, Blacksmith, Cingulate, Corcept, Denali, GSK, Johnson & Johnson, Legend, Krystal, Rocket.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biolytical Labs, Centinel Spine, Medtronic, Relu.ai, Simergent.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Avidity, Beone, Bicara, Lundbeck, Mannkind, Medincell, Revir, Teva.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Celltrion, Cosmo, Neurizon.